Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Nephros Inc (NEPH)

Nephros Inc (NEPH)
1.36 x 1 1.94 x 1
Post-market by (Cboe BZX)
1.89 -0.08 (-4.06%) 04/22/25 [NASDAQ]
1.36 x 1 1.94 x 1
Post-market 1.89 unch (unch) 15:59 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.89
Day High
1.97
Open 1.97
Previous Close 1.97 1.97
Volume 5,000 5,000
Avg Vol 12,160 12,160
Stochastic %K 52.47% 52.47%
Weighted Alpha -7.27 -7.27
5-Day Change -0.1250 (-6.20%) -0.1250 (-6.20%)
52-Week Range 1.3643 - 2.5500 1.3643 - 2.5500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,882
  • Shares Outstanding, K 10,600
  • Annual Sales, $ 14,160 K
  • Annual Income, $ 70 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.05
  • Price/Sales 1.50
  • Price/Cash Flow 99.94
  • Price/Book 2.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +499,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5100 +25.17%
on 03/24/25
Period Open: 1.5500
2.2190 -14.83%
on 04/03/25
+0.3400 (+21.94%)
since 03/21/25
3-Month
1.3900 +35.97%
on 03/03/25
Period Open: 1.6000
2.2190 -14.83%
on 04/03/25
+0.2900 (+18.12%)
since 01/22/25
52-Week
1.3643 +38.53%
on 10/24/24
Period Open: 2.0900
2.5500 -25.88%
on 05/17/24
-0.2000 (-9.57%)
since 04/22/24

Most Recent Stories

More News
Nephros to Present at LD Micro Main Event XVI

South Orange, New Jersey--(Newsfile Corp. - September 19, 2023) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets,...

NEPH : 1.8900 (-4.06%)
Nephros to Present at LD Micro Invitational XIII

South Orange, New Jersey--(Newsfile Corp. - May 24, 2023) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today...

NEPH : 1.8900 (-4.06%)
Nephros Announces Results for Quarter Ended June 30, 2022

Second Quarter Net Revenue of $2.9 Million, a 27% Year-Over-Year Increase;Active Customer Sites Climb 21% to New Record SOUTH ORANGE, NJ, Aug. 10, 2022...

NEPH : 1.8900 (-4.06%)
Nephros Second Quarter 2022 Financial Results Conference Call

SOUTH ORANGE, NJ, July 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing...

NEPH : 1.8900 (-4.06%)
Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months

Second Quarter Revenue of $2.9 Million, Year-Over-Year Increase of 27%;Number of Active Customer Sites Climbs 21% Year-Over-Year SOUTH ORANGE, NJ, July ...

NEPH : 1.8900 (-4.06%)
Nephros Receives FDA 510(k) Clearance for HDF Assist Module

The First and Only FDA-Cleared Device Available in the United States to Provide Hemodiafiltration Therapy to Dialysis Patients SOUTH ORANGE, NJ, May 17,...

NEPH : 1.8900 (-4.06%)
Nephros Announces Results for Quarter Ended March 31, 2022

First Quarter Net Revenue of $2.2 Million;Active Customer Sites Climb 17% to New Record SOUTH ORANGE, NJ, May 04, 2022 (GLOBE NEWSWIRE) -- via...

NEPH : 1.8900 (-4.06%)
Nephros First Quarter 2022 Financial Results Conference Call

SOUTH ORANGE, NJ, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing...

NEPH : 1.8900 (-4.06%)
Nephros Unveils New Branding and Website

Rebrand reflects an integrated approach to water safety, with expanded focus on customer solutions and educational resources  SOUTH ORANGE, NJ,...

NEPH : 1.8900 (-4.06%)
Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

SOUTH ORANGE, NJ, March 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing...

NEPH : 1.8900 (-4.06%)

Business Summary

Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider.

See More

Key Turning Points

3rd Resistance Point 2.0232
2nd Resistance Point 1.9965
1st Resistance Point 1.9433
Last Price 1.8900
1st Support Level 1.8634
2nd Support Level 1.8367
3rd Support Level 1.7835

See More

52-Week High 2.5500
Fibonacci 61.8% 2.0971
Fibonacci 50% 1.9571
Last Price 1.8900
Fibonacci 38.2% 1.8172
52-Week Low 1.3643

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro